BJ's Wholesale Club, Verint Systems And 2 Other Stocks Insiders Are Selling - BJ's Wholesale Club Hldgs (

The S&P 500 closed lower on Monday. Investors, meanwhile, focused on some notable insider trades.

When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company’s prospects or that they view the stock as being overpriced. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.

Below is a look at a few recent notable insider sales. For more, check out Benzinga's insider transactions platform.

BJ's Wholesale Club

The Trade: BJ's Wholesale Club Holdings, Inc. (NYSE:BJ) EVP, Chief Digital Officer Monica Schwartz sold a total of 15,168 shares at an average price of $61.85. The insider received around $938,140 from selling those shares.
What’s Happening: BJ's Wholesale Club reported worse-than-expected first-quarter sales results.
What BJ's Wholesale Club Does: BJ's Wholesale Club Holdings Inc is a warehouse club and gas station operator.
Have a look at our premarket coverage here

Verint Systems

The Trade: Verint Systems Inc. (NASDAQ:VRNT) Director Richard N Nottenburg sold a total of 3,000 shares at an average price of $34.82. The insider received around $104,445 from selling those shares.
What’s Happening: Verint Systems posted better-than-expected quarterly results.
What Verint Systems Does: Verint Systems Inc with its subsidiaries helps brands provide Boundless Customer Engagement.

Warby Parker

The Trade: Warby Parker Inc. (NYSE:WRBY) 10% owner Durable Capital Partners LP sold a total of 24,151 shares at an average price of $11.91. The insider received around $287,638 from selling those shares.
What’s Happening: Warby Parker posted upbeat first-quarter earnings.
What Warby Parker Does: Warby Parker Inc is engaged in designing and developing designer prescription glasses and contacts to eye exams and vision tests.

Arcus Biosciences

The Trade: Arcus Biosciences, Inc. (NASDAQ:RCUS) Chief Operating Officer Jennifer Jarrett sold a total of 12,437 shares at an average price of $19.12. The insider received around $237.8 thousand from selling those shares.
What’s Happening: Gilead Sciences and Arcus Biosciences expanded partnership to include research programs in inflammation.
What Arcus Biosciences Does: Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer.

Check This Out: Top 5 Materials Stocks That Are Preparing To Pump This Month

BJBJ's Wholesale Club Holdings Inc

$91.35-1.74%

Overview

RCUSArcus Biosciences Inc

$25.18-0.71%

WRBYWarby Parker Inc

$29.41-0.47%

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.